Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide in Short Bowel Syndrome (Extension of CL0600-004)
NCT00172185Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2005
- Primary completion
- Jan 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started Jan 2005; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT00172185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00172185.